“My takeaway: Commercial negotiated price reflects hospitals’ market power,” the JAMA study's author told Radiology Business. 

Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

The aim of the biotech company is to “transform healthcare by providing comprehensive information on patient predisposition to disease, disease prevention and personalized intervention and treatments."

A teenager went into cardiac arrest on an American Airlines flight from Honduras to Miami. He never recovered, and now his family has filed a new lawsuit that blames the airline.

Diving deeper into the data, researchers noted that 40.8% of the payments were tied to speaker fees. Another 19% were from consulting fees.

The state of California and Civica Rx have penned a 10-year deal to deliver insulin at a reduced rate. The medicines will be available in vials and prefilled pens under the CalRx label. 

“Despite these challenges, we were able to deliver solid performance and have positioned the business for strong organic growth," said CEO Riadh Zine. 

The round was led by two new investors, Novo Holdings and Andera Partners. Several existing investors, including Medtronic, also participated.